NAVIO Trademark

Trademark Overview


On Friday, January 19, 2018, a trademark application was filed for NAVIO with the United States Patent and Trademark Office. The USPTO has given the NAVIO trademark a serial number of 87763013. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 11, 2023. This trademark is owned by Navio Theragnostics, Inc.. The NAVIO trademark is filed in the Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Physician support services in the nature of providing legal consultation in the dispensing of prescription drugs for persons with particular cancers; providing survivorship information in the field of oncology, namely, legal advice regarding survivorship; provide individualized expert legal advice and diagnosis

Medical services in the field of oncology, nephrology; dispensing of pharmaceuticals; medical and pharmaceutical consultation; pharmaceutical advice; pharmaceutical compounding services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis, treatment and prevention purposes; providing genetic sequencing and consulting services via website designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians via a website to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cance...

Medical, clinical and scientific research in the field of oncology, namely, research relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; scientific and technological services, namely, research services for medical purposes in the field of genetic diagnostic assays and pharmaceuticals research for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information and scientific consulting in the field of genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; conducting early evaluations in the field of new genetic diagnostics assays and pharmaceuticals; development, evaluation and medical and scientific research of genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; laboratory research services relating to genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer...
navio

General Information


Serial Number87763013
Word MarkNAVIO
Filing DateFriday, January 19, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 20, 2020

Trademark Statements


Goods and ServicesPhysician support services in the nature of providing legal consultation in the dispensing of prescription drugs for persons with particular cancers; providing survivorship information in the field of oncology, namely, legal advice regarding survivorship; provide individualized expert legal advice and diagnosis
Translation of Words in MarkThe English translation of "NAVIO" in the mark is "SHIP".
Goods and ServicesMedical services in the field of oncology, nephrology; dispensing of pharmaceuticals; medical and pharmaceutical consultation; pharmaceutical advice; pharmaceutical compounding services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis, treatment and prevention purposes; providing genetic sequencing and consulting services via website designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians via a website to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; drug utilization review dispensing services via a website, namely, identifying cancer drug therapies based on a patient's genetic testing results prior to dispensing medications; developing and managing comprehensive treatment programs involving drug therapy, namely, providing comprehensive medical treatment programs involving drug therapy for the treatment of cancer; physician support services in the nature of providing medical consultation in the dispensing of prescription drugs for persons with particular cancers; providing medical evaluations of patients to determine acceptability for participation in clinical trials; providing healthcare medical counseling, screening, diagnosis, prognosis, treatment, relapse, palliative, integrative medicine, survivorship information, namely, providing comprehensive medical treatment programs involving drug therapy, and other related medical information in the field of oncology; Health care services, namely, providing a database in the field of oncology information and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions; providing an online searchable database in the fields of oncology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for personalized diagnosis, treatment and prevention of cancer; molecular profiling for providing comprehensive medical treatment programs involving drug therapy for providing medical treatment; providing RNA expression analysis for medical treatment and diagnosis; providing personalized immunotherapy; Medical services, namely, providing cancer diagnosis; providing standard diagnostics and comprehensive diagnostics, namely, providing standard and comprehensive medical testing for diagnostic purposes; medical services, namely, providing personalized drug screening; providing real-time therapeutic response monitoring for medical treatment and diagnostic purposes; provide individualized expert medical advice and diagnosis in the field of oncology; provide machine learning based medical treatment for cancer patients; providing personalized molecular tumor for each patient, namely, providing medical treatment in the nature of providing personalized molecular tumor for each patient for the treatment of cancer; molecular profiling for oncology treatment purposes; providing RNA expression analysis for oncology treatment purposes; providing standard diagnostics and comprehensive diagnostics, namely, oncology patient diagnostic services for medical treatment purposes; providing personalized drug screening for oncology patients for medical purposes; providing real-time therapeutic response monitoring for oncology patients for medical purposes; providing personalized drug screening for medical treatment and diagnostic purposes; provide machine learning based treatment in the nature of medical treatment and diagnostic purposes for cancer patients
Goods and ServicesMedical, clinical and scientific research in the field of oncology, namely, research relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; scientific and technological services, namely, research services for medical purposes in the field of genetic diagnostic assays and pharmaceuticals research for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information and scientific consulting in the field of genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; conducting early evaluations in the field of new genetic diagnostics assays and pharmaceuticals; development, evaluation and medical and scientific research of genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; laboratory research services relating to genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals, clinical trials and genetics; technical consulting related to scientific and medical studies in the field of genetic diagnostic assay and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; basic and clinical research in the field of oncology, namely, researching genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals and clinical trials for personalized diagnosis, treatment and prevention of cancer; custom design and development of chemical reagents and multiplex sequencing assays for personalized diagnosis, treatment and prevention of cancer; providing an on-line computer database featuring medical and scientific research information in the field of oncology that allows for input and collection of scientific and research data and information relating to genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, data mining and pattern recognition, designing clinical studies, and generating genomic data from patient samples for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection of mathematical and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to cancer treatments for personalized diagnosis, treatment and prevention of cancer; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies for personalized diagnosis, treatment and prevention of cancer; providing a website featuring technology with a web-based interface where medical professionals can view genetic test results and interpretations of the results by scientists and medical professionals in the field of genomics, and select the appropriate treatment and order the necessary pharmaceutical products; providing personalized molecular tumor for each patient, namely, providing medical research information regarding personalized molecular tumor treatments; providing medical research and scientific research information in the field of oncology via the Internet; development of a personalized ctDNA (circulating tumor DNA) assay; molecular profiling for scientific research purposes; providing RNA expression analysis for scientific research purposes; providing standard diagnostics and comprehensive diagnostics, namely, oncology patient diagnostic services for scientific research purposes; providing personalized drug screening for oncology patients for medical research purposes; providing real-time therapeutic response monitoring for oncology patients for medical research purposes; providing crowdsourcing platform in the nature of providing online non-downloadable software for obtaining information and input into a take or project by enlisting the services of a large number of people; molecular profiling for providing comprehensive medical treatment programs involving drug therapy for providing medical research; providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes, namely, providing a computer database in the field of oncology for treatment and diagnosis purposes featuring technology that allows users to input and collect data and information

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 31, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 31, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 8, 2018
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNavio Theragnostics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94401

Party NameNavio Theragnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94401

Trademark Events


Event DateEvent Description
Monday, September 11, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 11, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 31, 2023SOU EXTENSION 4 GRANTED
Tuesday, January 31, 2023SOU EXTENSION 4 FILED
Tuesday, January 31, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2022SOU EXTENSION 3 GRANTED
Monday, August 8, 2022SOU EXTENSION 3 FILED
Monday, August 8, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 9, 2022SOU EXTENSION 2 GRANTED
Wednesday, February 9, 2022SOU EXTENSION 2 FILED
Wednesday, February 9, 2022SOU TEAS EXTENSION RECEIVED
Saturday, August 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 5, 2021SOU EXTENSION 1 GRANTED
Thursday, August 5, 2021SOU EXTENSION 1 FILED
Thursday, August 5, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 30, 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, November 13, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 20, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 14, 2020EXPARTE APPEAL TERMINATED
Monday, September 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 3, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, September 3, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 3, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, September 3, 2020EXAMINERS AMENDMENT -WRITTEN
Saturday, August 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 12, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, August 12, 2020EX PARTE APPEAL-INSTITUTED
Wednesday, August 12, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, August 12, 2020EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, February 18, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 18, 2020FINAL REFUSAL E-MAILED
Tuesday, February 18, 2020FINAL REFUSAL WRITTEN
Friday, January 24, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, June 19, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 14, 2019ASSIGNED TO LIE
Thursday, November 29, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 29, 2018LETTER OF SUSPENSION E-MAILED
Thursday, November 29, 2018SUSPENSION LETTER WRITTEN
Thursday, November 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 8, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 8, 2018NON-FINAL ACTION E-MAILED
Tuesday, May 8, 2018NON-FINAL ACTION WRITTEN
Monday, April 30, 2018ASSIGNED TO EXAMINER
Wednesday, January 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 23, 2018NEW APPLICATION ENTERED